These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Extremely high birth prevalence of sickle cell disease in rural Tanzania. Eastburg L, Peckham A, Kawira E, Chirangi B, Adler D, Akungo BD, Smart LR, Ambrose EE. Pediatr Blood Cancer; 2020 Nov; 67(11):e28620. PubMed ID: 32803850 [Abstract] [Full Text] [Related]
7. Feasibility and acceptability of early infant screening for sickle cell disease in Lagos, Nigeria-A pilot study. Oluwole EO, Adeyemo TA, Osanyin GE, Odukoya OO, Kanki PJ, Afolabi BB. PLoS One; 2020 Nov; 15(12):e0242861. PubMed ID: 33270733 [Abstract] [Full Text] [Related]
8. HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges. Nnodu O, Isa H, Nwegbu M, Ohiaeri C, Adegoke S, Chianumba R, Ugwu N, Brown B, Olaniyi J, Okocha E, Lawson J, Hassan AA, Diaku-Akinwumi I, Madu A, Ezenwosu O, Tanko Y, Kangiwa U, Girei A, Israel-Aina Y, Ladu A, Egbuzu P, Abjah U, Okolo A, Akbulut-Jeradi N, Fernandez M, Piel FB, Adekile A. Blood Cells Mol Dis; 2019 Sep; 78():22-28. PubMed ID: 30773433 [Abstract] [Full Text] [Related]
9. Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening. Kunz JB, Awad S, Happich M, Muckenthaler L, Lindner M, Gramer G, Okun JG, Hoffmann GF, Bruckner T, Muckenthaler MU, Kulozik AE. Ann Hematol; 2016 Feb; 95(3):397-402. PubMed ID: 26658910 [Abstract] [Full Text] [Related]
10. Multicenter Evaluation of HemoTypeSC as a Point-of-Care Sickle Cell Disease Rapid Diagnostic Test for Newborns and Adults Across India. Mukherjee MB, Colah RB, Mehta PR, Shinde N, Jain D, Desai S, Dave K, Italia Y, Raicha B, Serrao E. Am J Clin Pathol; 2020 Jan 01; 153(1):82-87. PubMed ID: 31433854 [Abstract] [Full Text] [Related]
12. Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action. Colombatti R, Martella M, Cattaneo L, Viola G, Cappellari A, Bergamo C, Azzena S, Schiavon S, Baraldi E, Dalla Barba B, Trafojer U, Corti P, Uggeri M, Tagliabue PE, Zorloni C, Bracchi M, Biondi A, Basso G, Masera N, Sainati L. Pediatr Blood Cancer; 2019 May 01; 66(5):e27657. PubMed ID: 30724025 [Abstract] [Full Text] [Related]
13. Newborn screening for sickle cell disease in Kisangani, Democratic Republic of the Congo: an update. Kasai ET, Gulbis B, Ntukamunda JK, Bours V, Batina Agasa S, Marini Djang'eing'a R, Boemer F, Katenga Bosunga G, Ngbonda Dauly N, Sokoni Vutseme J, Boso Mokili B, Alworong'a Opara JP. Hematology; 2023 Dec 01; 28(1):2213043. PubMed ID: 37183964 [Abstract] [Full Text] [Related]
14. Early diagnosis of sickle cell disease at birth hospitals and vaccination centers in Angola using point-of-care tests. Olaniyan HS, Briscoe C, Muhongo M, Pascoal R, Armando A, Santos B, McGann PT. Blood Adv; 2023 Oct 10; 7(19):5860-5867. PubMed ID: 37399450 [Abstract] [Full Text] [Related]
16. Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study. Tubman VN, Marshall R, Jallah W, Guo D, Ma C, Ohene-Frempong K, London WB, Heeney MM. Pediatr Blood Cancer; 2016 Apr 10; 63(4):671-6. PubMed ID: 26739520 [Abstract] [Full Text] [Related]
17. Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania. Christopher H, Josephat E, Kaywanga F, Saul S, Mshana I, Kunambi P, Nasser A, Chamba C, Makani J, Nkya S. Int J Lab Hematol; 2022 Oct 10; 44(5):959-965. PubMed ID: 35775883 [Abstract] [Full Text] [Related]
18. Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting. Alvarez OA, Hustace T, Voltaire M, Mantero A, Liberus U, Saint Fleur R. Pediatrics; 2019 Oct 10; 144(4):. PubMed ID: 31530717 [Abstract] [Full Text] [Related]